Elekta AB (publ) (OTCMKTS:EKTAY) Short Interest Up 200.0% in February

Elekta AB (publ) (OTCMKTS:EKTAY - Get Free Report) saw a significant increase in short interest in the month of February. As of February 15th, there was short interest totalling 300 shares, an increase of 200.0% from the January 31st total of 100 shares. Based on an average daily trading volume, of 6,300 shares, the short-interest ratio is currently 0.0 days.

Analyst Upgrades and Downgrades

Separately, Sanford C. Bernstein raised Elekta AB (publ) from a "strong sell" rating to a "hold" rating in a research note on Wednesday, January 29th.

Elekta AB (publ) Trading Up 3.8 %

OTCMKTS EKTAY traded up $0.21 during trading hours on Tuesday, hitting $5.75. 1,270 shares of the company's stock were exchanged, compared to its average volume of 9,015. The stock has a 50-day simple moving average of $5.72 and a 200 day simple moving average of $6.06. Elekta AB has a 1-year low of $5.25 and a 1-year high of $8.24. The firm has a market cap of $2.21 billion, a price-to-earnings ratio of 23.00 and a beta of 1.22. The company has a current ratio of 1.05, a quick ratio of 0.81 and a debt-to-equity ratio of 0.60.

Elekta AB (publ) (OTCMKTS:EKTAY - Get Free Report) last released its earnings results on Friday, February 21st. The company reported $0.08 EPS for the quarter, missing the consensus estimate of $0.09 by ($0.01). Elekta AB (publ) had a return on equity of 11.07% and a net margin of 5.65%. The business had revenue of $416.86 million for the quarter, compared to analyst estimates of $435.89 million. On average, equities analysts forecast that Elekta AB will post 0.36 EPS for the current fiscal year.

Remove Ads

Elekta AB (publ) Cuts Dividend

The firm also recently announced a dividend, which will be paid on Thursday, March 27th. Investors of record on Friday, March 7th will be paid a dividend of $0.1072 per share. The ex-dividend date is Friday, March 7th. Elekta AB (publ)'s dividend payout ratio is currently 40.00%.

About Elekta AB (publ)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.